Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants
Claudio Fenizia, Silvia Galbiati, Claudia Vanetti, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

iPSC‐derived human cortical organoids display profound alterations of cellular homeostasis following SARS‐CoV‐2 infection and Spike protein exposure
Gioia Cappelletti, Lorenzo Brambilla, Sergio Strizzi, et al.
The FASEB Journal (2025) Vol. 39, Iss. 4
Open Access | Times Cited: 2
SARS-CoV-2 mitochondrial metabolic and epigenomic reprogramming in COVID-19
Joseph W. Guarnieri, Jeffrey Haltom, Yentli E. Soto Albrecht, et al.
Pharmacological Research (2024) Vol. 204, pp. 107170-107170
Open Access | Times Cited: 11
Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics
Yash Gupta, Oleksandr V. Savytskyi, Matt Coban, et al.
Molecular Aspects of Medicine (2022) Vol. 91, pp. 101151-101151
Open Access | Times Cited: 30
Host-targeted antivirals against SARS-CoV-2 in clinical development - prospect or disappointment?
André Schreiber, Stephan Ludwig
Antiviral Research (2025) Vol. 235, pp. 106101-106101
Open Access
PROTAC targeting cyclophilin A controls virus-induced cytokine storm
Heqiao Li, Wenxian Yang, Huizi Li, et al.
iScience (2023) Vol. 26, Iss. 9, pp. 107535-107535
Open Access | Times Cited: 9
A review of immune modulators and immunotherapy in infectious diseases
P. Vijayan, J.G. Xavier, Mohanan Parayanthala Valappil
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 8, pp. 1937-1955
Closed Access | Times Cited: 7
Human motor neurons derived from induced pluripotent stem cells are susceptible to SARS-CoV-2 infection
Gioia Cappelletti, Claudia Colombrita, Fiona Limanaqi, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 7
Cyclosporine A-Induced Systemic Metabolic Perturbations in Rats: A Comprehensive Metabolome Analysis
Nguyen Thi Hai Yen, Nguyen Tran Nam Tien, Nguyễn Thị Vân Anh, et al.
Toxicology Letters (2024) Vol. 395, pp. 50-59
Closed Access | Times Cited: 2
The critical impacts of cytokine storms in respiratory disorders
Shahana Riyaz Tramboo, Ahmed M. E. Elkhalifa, Syed Quibtiya, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e29769-e29769
Open Access | Times Cited: 2
Innate immunity and immunotherapy for hemorrhagic shock
Qingxia Huang, Song Gao, Yao Yao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Network-based Multi-omics Disease–Drug Associations Reveal Drug Repurposing Candidates for Covid-19 Disease Phases
Francis E. Agamah, Thomas H. A. Ederveen, Michelle Skelton, et al.
Drug repurposing (2024) Vol. 1, Iss. 1
Open Access | Times Cited: 1
Cyclosporine may reduce the risk of symptomatic COVID-19 in patients with systemic lupus erythematosus: a retrospective cohort study
Hejun Li, Rose S.Y. Lin, Yanqing Wang, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 11
Open Access | Times Cited: 1
SARS-CoV-2 hampers dopamine production in iPSC-derived dopaminergic neurons
Gioia Cappelletti, Emma Veronica Carsana, Giulia Lunghi, et al.
Experimental and Molecular Pathology (2023) Vol. 134, pp. 104874-104874
Open Access | Times Cited: 3
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro
Davide D’Angelo, Eride Quarta, Stefania Glieca, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 1023-1023
Open Access | Times Cited: 3
SARS‐CoV‐2 in digital era: Diagnostic techniques and importance of nucleic acid quantification with digital PCRs
Neeraj Kumar, S. Aradhana, Harleen, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 5
Closed Access | Times Cited: 2
Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2–Induced Inflammation
Fan Yang, Chenglong Liu, Pengyuan Li, et al.
Molecular Pharmacology (2023) Vol. 104, Iss. 6, pp. 239-254
Closed Access | Times Cited: 2
Antiviral Activity of a Cyclic Pro-Pro-β3-HoPhe-Phe Tetrapeptide against HSV-1 and HAdV-5
Ewa Zaczyńska, Krzysztof Kaczmarek, Janusz Zabrocki, et al.
Molecules (2022) Vol. 27, Iss. 11, pp. 3552-3552
Open Access | Times Cited: 3
A Review of Potential Therapeutic Strategies for COVID-19
Jiajia Meng, Ruijiao Li, Zhiqi Zhang, et al.
Viruses (2022) Vol. 14, Iss. 11, pp. 2346-2346
Open Access | Times Cited: 3
Nsp1 facilitates SARS-CoV-2 replication through calcineurin-NFAT signaling
Wai‐Yin Lui, Chon Phin Ong, Pak‐Hin Hinson Cheung, et al.
mBio (2024) Vol. 15, Iss. 4
Open Access
Network-based multi-omics-disease-drug associations reveal drug repurposing candidates for COVID-19 disease phases
Francis E. Agamah, Thomas H. A. Ederveen, Michelle Skelton, et al.
(2024)
Open Access
Antiviral history and viral targets for antiviral therapy
Akram Hegazy, Sara H. Mahmoud, Ahmed Magdy Khalil, et al.
Elsevier eBooks (2024), pp. 219-275
Closed Access
Voclosporin and the Antiviral Effect Against SARS-CoV-2 in Immunocompromised Kidney Patients
Eline J. Arends, Soufian Meziyerh, Dirk Jan A. R. Moes, et al.
Kidney International Reports (2023) Vol. 8, Iss. 12, pp. 2654-2664
Open Access | Times Cited: 1
Cyclosporine A therapy in patients with COVID-19 and failure of immunosuppression therapy: a retrospective cohort propensity-score matched analysis
З. М. Мержоева, Andrey I. Yaroshetskiy, S. A. Savko, et al.
Annals of critical care (2023), Iss. 4, pp. 125-138
Open Access | Times Cited: 1
Valorization of Cheese Whey as a Feedstock for Production of Cyclosporin A by Tolypocladium inflatum
Hyeong Ryeol Kim, Kang Hyun Lee, Youngsang Chun, et al.
Fermentation (2022) Vol. 8, Iss. 12, pp. 670-670
Open Access | Times Cited: 2
Induction of antiviral gene expression by cyclosporine A, but not inhibition of cyclophilin A or B, contributes to its restriction of human coronavirus 229E infection in a lung epithelial cell line
John E. Mamatis, Carla E. Gallardo-Flores, Taylor Walsh, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1 - Next Page

Scroll to top